HF leads to reduced BA secretion and diminished conversion to secondary BAs, with mechanisms showing marked heterogeneity: certain BAs exert cardioprotective effects through anti-inflammatory and antioxidant pathways, while others may induce cardiac injury at specific dose levels
This can result in more muscle mass, improved fat metabolism, enhanced skin quality, and potentially anti-aging effects
Those who may not be a good candidate for GLP-1 medication use severe gastrointestinal diseases (e.g., inflammatory bowel disease) a personal or family history of multiple endocrine neoplasia 2A or 2B a personal or family history of medullary thyroid cancer a history of pancreatitis If youre in perimenopause, pregnancy is still possible, and doctors advise against using semaglutide during pregnancy
Additionally, the conversion process doesnt yield enough K2 that your body needs, hence the need to get K2 from other sources like food and supplements
the next step shows a way to make these tradeoffs feel less like guesswork and more like a plan
I think theres particularly an advantage of CagriSema in patients with type 2 diabetes for that reason